cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer

This publication has 24 references indexed in Scilit:

• Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
  Lung Cancer, 2005
• American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
  Journal of Clinical Oncology, 2004
• Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine
  British Journal of Haematology, 2003
• Nucleoside analogues and nucleobases in cancer treatment
  The Lancet Oncology, 2002
• Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
  Drug Resistance Updates, 2002
• Nucleoside analogues: mechanisms of drug resistance and reversal strategies
  Leukemia, 2001
• Recent molecular advances in studies of the concentrative Na+-dependent nucleoside transporter (CNT) family: identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)
  Molecular Membrane Biology, 2001
• Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562
  British Journal of Haematology, 1999
• A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
  Journal of Clinical Oncology, 1991
• Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.
  Proceedings of the National Academy of Sciences, 1979